AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimefest Trio 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimefest Trio 2mg/500mg/0.3mg Tablet

TriadGlyc 2mg/500mg/0.3mg tablets are antidiabetic medications combining three agents to manage type 2 diabetes in adults. This combination helps regulate blood glucose. Take TriadGlyc with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are vital preventative measures. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting TriadGlyc. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimefest Trio 2mg/500mg/0.3mg Tablet

The information is unavailable.

Uses of Glimefest Trio 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Glimefest Trio 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimefest Trio 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimefest Trio 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimefest Trio 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Glimefest Trio 2mg/500mg/0.3mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer on an empty stomach.

How Glimefest Trio 2mg/500mg/0.3mg Tablet works:

This tablet, Glimefest Trio (2mg/500mg/0.3mg), contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glimefest Trio 2mg/500mg/0.3mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimefest Trio 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimefest Trio 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glimefest Trio 2mg/500mg/0.3mg tablets is inadvisable for individuals with kidney impairment and should be forgone. Medical advice is necessary. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver disease should use Glimefest Trio 2mg/500mg/0.3mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver impairment, initiation should be at a low dosage; however, the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimefest Trio 2mg/500mg/0.3mg Tablet :

Should you forget a Glimefest Trio 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimefest Trio 2mg/500mg/0.3mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Glimefest Trio 2mg/500mg/0.3mg Tablet

Glimefest Trio 2mg/500mg/0.3mg tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar levels. This formulation is unsuitable for treating type 1 diabetes.
Glimefest Trio 2mg/500mg/0.3mg Tablets may cause common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, flatulence, abdominal pain, headache, skin eruptions, and respiratory infections.
Glimefest Trio 2mg/500mg/0.3mg Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. This medication should also be omitted in patients exhibiting moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and underlying metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Glimefest Trio 2mg/500mg/0.3mg tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Glimefest Trio 2mg/500mg/0.3mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glimefest Trio 2mg/500mg/...
153
MRP 186
17% off